| Canagliflozin and cardiovascular and renal events in type 2 diabetes B Neal, V Perkovic, KW Mahaffey, D De Zeeuw, G Fulcher, N Erondu, ... New England Journal of Medicine 377 (7), 644-657, 2017 | 8544 | 2017 |
| Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of … AR Lyon, E Bossone, B Schneider, U Sechtem, R Citro, SR Underwood, ... European journal of heart failure 18 (1), 8-27, 2016 | 1278 | 2016 |
| The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 B Vogel, M Acevedo, Y Appelman, CNB Merz, A Chieffo, GA Figtree, ... The Lancet 397 (10292), 2385-2438, 2021 | 1088 | 2021 |
| Biological markers of oxidative stress: applications to cardiovascular research and practice E Ho, KK Galougahi, CC Liu, R Bhindi, GA Figtree Redox biology 1 (1), 483-491, 2013 | 990 | 2013 |
| Canagliflozin and heart failure in type 2 diabetes mellitus: results from the CANVAS program K Radholm, G Figtree, V Perkovic, SD Solomon, KW Mahaffey, ... Circulation 138 (5), 458-468, 2018 | 540 | 2018 |
| The global burden of metabolic disease: Data from 2000 to 2019 NWS Chew, CH Ng, DJH Tan, G Kong, C Lin, YH Chin, WH Lim, ... Cell metabolism 35 (3), 414-428. e3, 2023 | 405 | 2023 |
| Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data GA Figtree, ST Vernon, N Hadziosmanovic, J Sundström, J Alfredsson, ... The Lancet 397 (10279), 1085-1094, 2021 | 238 | 2021 |
| Cardiac spheroids as promising in vitro models to study the human heart microenvironment L Polonchuk, M Chabria, L Badi, JC Hoflack, G Figtree, MJ Davies, ... Scientific reports 7 (1), 7005, 2017 | 229 | 2017 |
| Plant-derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism GA Figtree, H Griffiths, YQ Lu, CM Webb, K MacLeod, P Collins Journal of the American College of Cardiology 35 (7), 1977-1985, 2000 | 204 | 2000 |
| Reversible Oxidative Modification: A Key Mechanism of Na+-K+ Pump Regulation GA Figtree, CC Liu, S Bibert, EJ Hamilton, A Garcia, CN White, KKM Chia, ... Circulation research 105 (2), 185-193, 2009 | 201 | 2009 |
| Truncated estrogen receptor α 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase GA Figtree, D McDonald, H Watkins, KM Channon Circulation 107 (1), 120-126, 2003 | 195 | 2003 |
| The health digital twin to tackle cardiovascular disease—a review of an emerging interdisciplinary field G Coorey, GA Figtree, DF Fletcher, VJ Snelson, ST Vernon, D Winlaw, ... NPJ digital medicine 5 (1), 126, 2022 | 171 | 2022 |
| Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor–dependent and nitric oxide–dependent mechanism GA Figtree, Y Lu, CM Webb, P Collins Circulation 100 (10), 1095-1101, 1999 | 171 | 1999 |
| Effects of canagliflozin on heart failure outcomes associated with preserved and reduced ejection fraction in type 2 diabetes mellitus: results from the CANVAS program GA Figtree, K Rådholm, TD Barrett, V Perkovic, KW Mahaffey, D de Zeeuw, ... Circulation 139 (22), 2591-2593, 2019 | 169 | 2019 |
| Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors ST Vernon, S Coffey, R Bhindi, SY Soo Hoo, GI Nelson, MR Ward, ... European journal of preventive cardiology 24 (17), 1824-1830, 2017 | 168 | 2017 |
| ST‐segment–elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors—how common are they, and what are their outcomes? ST Vernon, S Coffey, M D'Souza, CK Chow, J Kilian, K Hyun, JA Shaw, ... Journal of the American Heart Association 8 (21), e013296, 2019 | 157 | 2019 |
| Vitamin D supplementation and bone mineral density in early postmenopausal women L Cooper, PB Clifton-Bligh, ML Nery, G Figtree, S Twigg, E Hibbert, ... The American journal of clinical nutrition 77 (5), 1324-1329, 2003 | 147 | 2003 |
| Mediators of the effects of canagliflozin on heart failure in patients with type 2 diabetes JW Li, M Woodward, V Perkovic, GA Figtree, HJL Heerspink, ... JACC: Heart Failure 8 (1), 57-66, 2020 | 141 | 2020 |
| Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with … CK Chow, ER Atkins, GS Hillis, MR Nelson, CM Reid, MP Schlaich, P Hay, ... The Lancet 398 (10305), 1043-1052, 2021 | 137 | 2021 |
| Empagliflozin after acute myocardial infarction J Butler, WS Jones, JA Udell, SD Anker, MC Petrie, J Harrington, ... New England Journal of Medicine 390 (16), 1455-1466, 2024 | 118 | 2024 |
Stuart GrieveThe University of SydneyВерификована је имејл адреса на sydney.edu.au
